Latest Southeast Asia News

Pureprofile Limited has reported a robust Q3 FY25 with revenue up 16% and EBITDA up 16% year-on-year, driving a 20% increase in year-to-date revenue and a 35% jump in EBITDA. The company’s international expansion and new AI-driven solutions underpin its confident outlook for FY25.

SportsHero Limited has made significant strides in commercialising its iGV Family Game Pass, securing key partnerships with major Southeast Asian telecom operators and expanding its market footprint to the Philippines.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

Nuchev Limited reported a remarkable 215% increase in quarterly revenue, driven by the strategic launch of Oli6® in Vietnam and the acquisition of bWellness, signaling robust expansion across key Asia-Pacific markets.

Triangle Energy reported a $9.85 million cash balance for the March quarter, plugged the Becos-1 well after disappointing results, and agreed to defer the Cliff Head asset sale to Pilot Energy until 2026.

Murray Cod Australia Ltd reports a remarkable 192% biomass increase, setting the stage for expanded domestic and international sales from May 2025. The company also advances sustainability certifications and strengthens its board to support growth.

Change Financial Limited delivered a record Q3 FY25 revenue of US$3.9 million, driven by strong growth in its Payments as a Service platform and recurring revenue streams, while substantially completing its US operations exit. The company is confident of surpassing 30% revenue growth and achieving its first underlying EBITDA positive result for FY25.

MyEco Group is streamlining its manufacturing footprint and expanding outsourced production to cut fixed costs by up to $3 million annually, aiming to enhance margins and achieve positive EBITDA in the medium term.

EBOS Group Limited announces the retirement of CEO John Cullity after a decade of strong growth, appointing Adam Hall as his successor to lead the company’s next phase of expansion.

EBOS Group Limited’s interim results for H1 2025 reveal a notable decrease in revenue and profit compared to the prior year, yet the company maintains its interim dividend, signaling confidence despite headwinds.

EBOS Group Limited posted robust interim results for H1 FY25, with underlying EBITDA rising 7.1% excluding the Chemist Warehouse Australia contract, driven by strong organic growth and strategic investments. The company maintained its dividend and reiterated FY25 EBITDA guidance between $575 million and $600 million.

EBOS Group Limited posted a strong half-year performance with underlying EBITDA up 7.1% to $291 million, driven by growth in healthcare and animal care segments, while maintaining its interim dividend amid the loss of the Chemist Warehouse contract.